This 3D printed protein model of EGFR TK Mutant Small Molecule Inhibitor 3W2O designed to be used with biologic model: EGFR TK Mutant without Inhibitor 3W2O. EGFR is in its active state, evident by the downward position of the active loop (orange), allowing for ATP to travel deep into its binding pocket. Bound to this binding pocket is TAK-285 (colored by atom type). This protein model is colored to visualize the atomic temperature and printed in full-color sandstone.
Epidermal growth factor receptor (EGFR) gene mutations (G719X, exon 19 deletions/insertions, L858R, and L861Q) predict favorable responses to EGFR tyrosine kinase inhibitors (TKIs) in advanced non-small cell lung cancer (NSCLC). However, EGFR exon 20 insertion mutations (~10% of all EGFR mutations) are generally associated with insensitivity to available TKIs (gefitinib, erlotinib, and afatinib). The basis of this primary resistance is poorly understood. We studied a broad subset of exon 20 insertion mutations, comparing in vitro TKI sensitivity with responses to gefitinib and erlotinib in NSCLC patients, and found that most are resistant to EGFR TKIs
Designed to be used with EGFR TK Mutant without Inhibitor (3W2O)
For international customers outside the US, please visit the model on our 3D printing service’s international website: LINK
Select the desired material finish and size below. Matte finish applies a UV protective, semi-glossy coating.
Created from PDB ID: 3W2O.